This Article Full Text Full Text (PDF) All Versions of this Article: 26/3/590    most recent 01.ATV.0000203519.25116.54v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chan, D. C. Articles by Barrett, P. H. R. Search for Related Content PubMed PubMed Citation Articles by Chan, D. C. Articles by Barrett, P. H. R. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Medline Plus Health Information Triglycerides

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:590.)
© 2006 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Apolipoproteins C-III and A-V as Predictors of Very-Low-Density Lipoprotein Triglyceride and Apolipoprotein B-100 Kinetics

Dick C. Chan; Gerald F. Watts; Minh N. Nguyen; P. Hugh R. Barrett

From Metabolic Research Center, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.

Correspondence to Professor Gerald F Watts, School of Medicine and Pharmacology, University of Western Australia, Royal Perth Hospital, GPO Box X2213, Perth, WA 6847, Australia. E-mail gfwatts{at}cyllene.uwa.edu.au

Objective— We investigated the associations between plasma very-low-density lipoprotein (VLDL)–apolipoprotein (apo)C-III and apoA-V concentrations and the kinetics of VLDL–apoB-100 and VLDL triglycerides in 15 men. We also explored the relationship between these parameters of VLDL metabolism and VLDL–apoC-III kinetics.

Methods and Results— ApoC-III, apoB, and triglyceride kinetics in VLDL were determined using stable isotopes and multicompartmental modeling to estimate production rate (PR) and fractional catabolic rate (FCR). Plasma VLDL–apoC-III concentration was significantly and inversely associated with the FCRs of VLDL triglycerides (r=–0.610) and VLDL–apoB (r=–0.791), and positively correlated with the PR of VLDL–apoC-III (r=0.842). However, apoA-V concentration was not significantly associated with any of the kinetic variables. There was a significant association (P<0.01) between the PRs of VLDL triglycerides and VLDL–apoB (r=0.641), and between the FCRs of VLDL triglycerides and VLDL–apoB (r=0.737). In multiple regression analysis, plasma VLDL–apoC-III concentration was a significant predictor of VLDL triglyceride FCR (ß-coefficient=–0.575) and VLDL–apoB FCR (ß-coefficient=–0.839).

Conclusions— Our findings suggest that increased VLDL–apoC-III concentrations resulting from an overproduction of VLDL–apoC-III are strongly associated with the delayed catabolism of triglycerides and apoB in VLDL. We also demonstrated that the kinetics of VLDL triglycerides and apoB are closely coupled. Our data do not support a role for plasma apoA-V in regulating VLDL kinetics.

We investigated the associations between plasma VLDL-apoC-III and apoA-V concentrations and the kinetics of VLDL-apoB-100 and VLDL triglyceride in 15 men. Increased VLDL-apoC-III concentrations resulting from an overproduction of VLDL-apoC-III was a predictor of the delayed catabolism of VLDL triglyceride and VLDL-apoB. However, apo-V concentration was not significantly associated with VLDL kinetics.

Key Words: apoA-V • apoC-III • cardiovascular disease • lipoprotein metabolism

This article has been cited by other articles:

				T. M. Forte, X. Shu, and R. O. Ryan The ins (cell) and outs (plasma) of apolipoprotein A-V J. Lipid Res., April 1, 2009; 50(Supplement): S150 - S155. [Abstract] [Full Text] [PDF]

				D. C. Chan, P. H. R. Barrett, E. M. M. Ooi, J. Ji, D. T. Chan, and G. F. Watts Very Low Density Lipoprotein Metabolism and Plasma Adiponectin as Predictors of High-Density Lipoprotein Apolipoprotein A-I Kinetics in Obese and Nonobese Men J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 989 - 997. [Abstract] [Full Text] [PDF]

				M. Pavlic, R. Valero, H. Duez, C. Xiao, L. Szeto, B. W. Patterson, and G. F. Lewis Triglyceride-Rich Lipoprotein-Associated Apolipoprotein C-III Production Is Stimulated by Plasma Free Fatty Acids in Humans Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1660 - 1665. [Abstract] [Full Text] [PDF]

				M. Adiels, S.-O. Olofsson, M.-R. Taskinen, and J. Boren Overproduction of Very Low-Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1225 - 1236. [Abstract] [Full Text] [PDF]

				D. C. Chan, M. N. Nguyen, G. F. Watts, and P. H. R. Barrett Plasma Apolipoprotein C-III Transport in Centrally Obese Men: Associations with Very Low-Density Lipoprotein Apolipoprotein B and High-Density Lipoprotein Apolipoprotein A-I Metabolism J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 557 - 564. [Abstract] [Full Text] [PDF]

				J. Kahri, J. Fruchart-Najib, N. Matikainen, J.-C. Fruchart, J. Vakkilainen, and M.-R. Taskinen The Increase of Apolipoprotein A-V During Postprandial Lipemia Parallels the Response of Triglyceride-Rich Lipoproteins in Type 2 Diabetes: No relationship between apoA-V and postheparin plasma lipolytic activity Diabetes Care, August 1, 2007; 30(8): 2083 - 2085. [Full Text] [PDF]

				C. Zheng, C. Khoo, K. Ikewaki, and F. M. Sacks Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions J. Lipid Res., May 1, 2007; 48(5): 1190 - 1203. [Abstract] [Full Text] [PDF]

				M. N. Nguyen, D. C. Chan, K. P. Dwyer, P. Bolitho, G. F. Watts, and P. H. R. Barrett Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma J. Lipid Res., June 1, 2006; 47(6): 1274 - 1280. [Abstract] [Full Text] [PDF]